Healthcare
Accrelist appoints CEO as China aesthetics strategy takes shape
Accrelist appoints CEO as China aesthetics strategy takes shape
Derek Cheong will lead the Xiamen clinic plan under the proposed 51% deal structure.
1 day ago
65LAB backs NUS biotech venture with $2.13m funding
The capital will help advance a treatment candidate for a chronic lung disease.
2 days ago
Home care cost gap strains over two-thirds of caregivers: report
Residents put monthly expenses at $2,400, below actual charges of $3,500.
3 days ago
A*STAR and NUS launch synthetic biology commercialisation lab
The facility will target nutrition consumer care and healthcare applications.
6 days ago
HC Surgical expands endoscopy footprint in NYK Endoscopy deal
It acquired 51% of the clinic for $750,000.
Parkway MediCentre taps AeviceMD for home asthma monitoring
The bottle cap-sized device tracks a child’s lung sounds continuously at night.
Researchers create nanosensor to detect gut health biomarker
It produces a rapid optical readout within minutes.
NUH, LASALLE launch sustainable medicine design lab
The lab brings together clinicians, designers, and students to develop practical design interventions.
ASTAR’s HERRO sharpens nanopore sequencing, tackling error‑prone reads
HERRO corrects nanopore sequencing errors and supports single-platform workflows.
Thomson Medical commercial chief Cassandra Loh named Singapore CEO
It will take effect on 1 July.
IHH Healthcare core profit up 3% in 2025 as revenue hits $6.6b
Core revenue rose 18%.
Jardine Matheson to buy I-MED Radiology for $3.1b
The deal gives it full control of I-MED clinics across Australia and New Zealand.
UltraGreen.ai invests $12.3m in LifeSignals, IHLD
The investments were funded from IPO proceeds and are not expected to materially affect FY2026 EPS.
iX restructures consumer-facing business to pursue US consumer health market
The newly incorporated holding company may pursue a public listing.
NUH redesigns workflows to reduce hospital bottlenecks
It has expanded nurse-led care and frontline decision-making.
SDAI gets shareholder nod to enter biotech and anti-ageing business
It targets the longevity market with skincare, supplements and moxibustion push.
Competition watchdog clears Zuellig Pharma deal for Lilly’s Cialis assets
CCS said the deal is unlikely to lessen competition in the ED medication market.
Read Here
Advertise
Sign Up
Commentary
Is Singapore's emphasis on long-term security and stability hindering purpose-driven employees?
When Singapore's agentic AI ‘chefs’ arrive, will the kitchen be ready for them?
What Singapore’s app store rules reveal about the future of online trust
Faster hiring alone will not fix construction’s productivity problem
Beyond policy: How Singapore's service sector can win at the frontline
Solving the production problem behind Singapore’s ‘pilot purgatory’
Transformation without disruption: Your Existing ERP is an accelerant to business innovation
From Singapore to Southeast Asia: Thriving in innovation by knowing when to pause
Section 13O, MAS, and the digital footprint of Singapore Family Offices